GLP-1 response to a mixed meal: What happens 10 years after Roux-en-Y Gastric Bypass (RYGB)?

Obesity Surgery

Volumn 22, Issue 7, 2012, Pages 1077-1083

  Dar, Moahad S ^a   Chapman III, William H ^a   Pender, John R ^a   Drake III, Almond J ^a   O'Brien, Kevin ^b   Tanenberg, Robert J ^a   Dohm, G Lynis ^a   Pories, Walter J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

BMI; GLP 1; Insulin resistance; Mixed meal; Roux en y gastric bypass; Type 2 diabetes

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FOLLOW UP; FOOD INTAKE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY WEIGHT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EATING; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84862620240     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0624-1     Document Type: Article

References (23)

1. Diabetes: World Health Organization, Geneva, Switzerland (2008). www.who.int/medicenter/factsheets/fs312/en.
2. Buchwald H, Estok R, Fahbach K, et al. Weight and type 2 diabetes after bariatric surgery: systemic review and meta-analysis. Am J Med. 2009;122(3):248-56.
3. Sjöström L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-93.
4. Holdstock C, Zethelisu B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes Lond. 2008;32(11):1540-6.
5. Goldfine AB, Mun EC, Devien E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92(12):4678-85.
6. Borg CM, Le Roux WE, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93(2):210-5.
7. Le Roux CW, Aylwin SJB, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108-14.
8. Korner J, Bessler M, Inabnet W, et al. Exaggerated GLP-1 and blunted GIP secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3(6):597-601.
9. Vidal J, Nicolau J, Romero F, et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. JCEM. 2009;94(3):884-91.
10. Laferrerre B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30(7):1709-16.
11. Isbell JM, Taboli RA, Hanse EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care. 2010;33(7):1438-42.
12. Kashyap SR, Daud S, Kelly Kr et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. In J Obes 2010; 34(30):462-71.
13. Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966-71.
14. Hansen EN, Tamboli RA, Isbell JM, et al. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Live Physiol. 2011;300:G795-802.
15. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1C point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56(1):44-52.
16. Knop FK, Vilsboll T, Larsen S, et al. Increase postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab. 2007;292:E324-33.
17. Bradley 3rd El, Isaacs JT, Mazo JD, et al. Pathophysiology and significance of malabsorption after Roux-en-Y reconstruction. Surgery. 1977;81(6):684-91.
18. Odstrcil EA, Martinez JG. Santa Ana CA et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704-13.
19. Guesbeck NR, Hickey MS, MacDonald KG, et al. Substrate utilization during exercise in formerly morbidly obese women. J Appl Physiol. 2001;90(3):1007-12.
20. VilsbØll, Krarup T, Sonne J, et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2003;88(6):2706-13.
21. Sjöström L, Narbro K, Sjöström CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-52.
22. Pories WJ, MacDonald Jr KG, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55(2 Suppl):582S-5S.
23. MacDonald KG, Long SD, Swanson MS. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1(3):213-20.